Navigation Links
2011 Proves Positive for UBM Live's Portfolio of Indian Pharma Events
Date:3/22/2012

AMSTERDAM, March 22, 2012 /PRNewswire/ -- Leading events organiser UBM Live, a division of UBM Plc (LSE: UBM), today announced that its India Pharma portfolio of events had a strong year in 2011. There was a positive growth in attendance figures over last year's Pharma events in Mumbai. Hosted from 30th November to 2nd December, 2011 at the Bombay Exhibition Centre, the line-up featured CPhI India for pharmaceutical ingredients, P-MEC India for pharmaceutical equipment, machinery and technology, ICSE India for contract services, clinical trials, and CROs and the BioPh trail for the biopharma market. Over three days, the events hosted 825 exhibitors from 21 different countries with an attendance of 27,437 people from 96 countries across the globe.

CPhI India and co-located events had top level exhibitor attendance from key industry companies such as BASF India, Lupin, Piramal Healthcare, Merck, SGS Life Science, and Aurobindo Pharma in 2011. The events were run in a traditional exhibition format with a complementary programme of networking and educational events run daily. New features included an exhibition tent in the parking area that acted as an extension of the venue and hosted over 100 new exhibitors. Returning features included the second year of the Conference Sessions which had strong attendance and covered hot industry topics such as Global Clinical Trials; Global Biosimilars Regulations; Healthcare and OTC Drugs; Developing Difficult Generics; Export Potential; and Competitive API Strategies. 

The Indian pharma market offers a unique business environment due to various factors including low cost of R&D and production, cutting edge technologies, and a well-educated and innovative work force. As the Indian pharma market grows, a focus is being placed on expansion through strategic investments and partnerships globally. Echoing this focus, CPhI India and co-located events were inaugurated by Martin O'Malley, Governor of Maryland, who came to Mumbai with a full delegation and plans to discuss how the Indian Government and Maryland can partner to support the pharma industry in Maryland.

"Our events have grown with this market organically. Especially over the past five years, we have seen India become the fourth largest pharma market globally and it is exciting to see the progress," noted Greg Kerwin, UBM Pharma Portfolio Director. He continued, "We are pleased to see that our customer base continues to grow and has positive feedback about the impact that the India pharma events have on their business. We work very hard to ensure that the events facilitate maximum exposure across the various sectors of the Indian Pharma market."

New exhibitor, Technoflex, confirmed that they saw immediate results from the event. Sylvie Ponlot, Communication Manager for the company commented, "This was our first CPhI India in Mumbai. We made contact with many new prospective clients and several customers. We strongly believe that new projects will result from our attendance. This was a really fruitful show for Technoflex and we will definitely be in Mumbai next year."

CPhI India, ICSE and P-MEC India will return to the Bombay Exhibition Centre in Mumbai from 21-23 November 2012. To learn more about CPhI India, please visit: http://www.cphi-india.com/home

UBM's market leading schedule of annual pharma events also includes Japan (21-23 March, 2012, Tokyo Big Sight Exhibition Centre, Japan), South East Asia (10-12 May, 2012, Jakarta International Expo, Indonesia), ICSE USA (22-23 May, 2012, Pennsylvania Convention Centre, Philadelphia), China (26-28 June, 2012, SNIEC, Shanghai, China), South America (21-23 August, 2012, Transamerica Expo Centre, Brazil) and Worldwide (9-11 October, 2012 at the Feria de Madrid, Spain).

Notes for Editors:

UBM Live is a division of UBM Plc (LSE: UBM) a leading provider of business information services to the maritime, travel, fashion, technology, healthcare, media, and property industries. UBM offers services in trade shows, online, news distribution, and publishing to customers across the globe. Its brands are represented in more than 30 countries and are organized into specialist teams that serve their business communities helping them excel in their market by working effectively and efficiently. For more information, go to www.ubmlive.com.


'/>"/>
SOURCE UBM Live
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. U.S. FDA Approves First and Only Oral Contraceptive Demonstrated to Treat Heavy Menstrual Bleeding (HMB)
2. FDA Approves Additional Manufacturer of Methoxsalen
3. Axion Healths ReadySet Software Proves Web-Based Electronic Health Records (EHR) Reduce Clinical Errors and Increase Compliance
4. FDA Approves New Skin Cancer Drug First Tested in Arizona by Scottsdale Healthcare and TGen
5. FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery
6. FDA Approves Gleevec For Expanded Use in Patients With Rare Gastrointestinal Cancer
7. FDA Approves Kalydeco to Treat Rare Form of Cystic Fibrosis
8. ASAM Approves Prescription Drug Policy
9. FDA Approves Picato® (ingenol mebutate) Gel, the First and Only Topical Actinic Keratosis (AK) Therapy With 2 or 3 Consecutive Days of Once-Daily Dosing
10. FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments
11. FDA Approves EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the Treatment of Hypertension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... Colo. , Feb. 22, 2017  Aytu BioScience, ... global commercialization of novel products in the field of ... team to up to 42 account managers from 35 ... The sales force expansion is being ... prescriptions and revenues, an indication of increasing acceptance of ...
(Date:2/22/2017)... PUNE, India , February 22, 2017 According ... (Spectroscopy, Chromatography), Measurement (On-Line, In-Line, At-Line), Products and Services (Analyzers, Probes & ... to 2021", published by MarketsandMarkets, the global market is poised to reach ... a CAGR of 13.3% from 2016 to 2021. ... ...
(Date:2/22/2017)... Feb. 22, 2017  CVS Pharmacy is the first ... partially hydrogenated oils (PHO), the primary source of artificial ... store brands food products. The retailer now offers over ... from artificial trans fats. This comes a year and a ... of June 2018 for processed foods to be reformulated ...
Breaking Medicine Technology:
(Date:2/22/2017)... MICHIGAN (PRWEB) , ... February 22, 2017 , ... ... analysis of issues related to spine practices, is featuring Michigan neurosurgeon Jay Jagannathan, ... known as one of a small number of neurosurgeons in Michigan performing minimally ...
(Date:2/22/2017)... ... 2017 , ... Michael J. Hennessy Associates, Inc. (MJH Associates), ... professionals and other key stakeholders with an array of valuable resources, Healthcare Analytics ... announced Michael J. Hennessy, Jr., president of MJH Associates. , In making ...
(Date:2/22/2017)... ... February 22, 2017 , ... Super-Sod will attend the ... event in Athens, Georgia. , A shift from Super-Sod’s simple Athens Home Show booth ... For the booth, grass seed plant manager Chris Roquemore constructed furniture from recycled pallet ...
(Date:2/22/2017)... ... February 22, 2017 , ... FPS is a ... PTSD. , Established in 1977, our organization was at the forefront in working ... to civilian life were evident and served as the catalyst for the establishing ...
(Date:2/22/2017)... Lexington, Kentucky (PRWEB) , ... February 22, 2017 ... ... the Journal of Patient Safety, patient advocates stress that the patient context (age, ... and not used as reasons to mitigate their occurrence. In addition, ...
Breaking Medicine News(10 mins):